Amgen vs Apple: Founders, CEOs and History
Amgen was founded in 1980 by George B. Rathmann, William K. Bowes Jr. and is led by Robert A. Bradway. Apple was founded in 1976 by Steve Jobs, Steve Wozniak, Ronald Wayne and is led by John Ternus.
Company facts
Founders
Amgen
George B. Rathmann
Amgen, originally incorporated as Applied Molecular Genetics, was founded in 1980 not by a single scientist, but by a calculated syndicate of venture capitalists and academics trying to commercialize the brand-new science of recombinant DNA.
William K. Bowes Jr.
William K. Bowes Jr. Was the venture capital strategist whose vision catalyzed Amgen's formation.
Apple
Steve Jobs
Apple Computer was founded on April 1, 1976, by Steve Jobs, Steve Wozniak, and Ronald Wayne, who sold his 10% stake back to his partners for $800 twelve days later.
Steve Wozniak
Steve Wozniak co-founded Apple and supplied the engineering foundation for its early success. He designed the Apple I as a working personal-computer board and then created the Apple II, the product that transformed Apple into a real company.
Ronald Wayne
Ronald Wayne co-founded Apple in 1976 but exited the partnership after only days, selling his stake back to Jobs and Wozniak.
CEOs and their tenures
Amgen
- George B. Rathmann1980–1988
Chief Executive Officer
George Rathmann, a physical chemist who had run research and development at Abbott Laboratories, was named Amgen's first chief executive in 1980 and worked from a small trailer so that laboratory space could go to scientists.
Source - Gordon M. Binder1988–2000
Chief Executive Officer
Gordon Binder joined Amgen as chief financial officer in 1982 and led its June 1983 initial public offering.
Source - Kevin W. Sharer2000–2012
Chief Executive Officer
Kevin Sharer joined Amgen in 1992 as president and chief operating officer and became chairman and chief executive in 2000.
Source - Robert A. Bradway2012–present
Chairman and Chief Executive Officer
Robert Bradway became chief executive on May 23, 2012, succeeding Kevin Sharer as the fourth CEO in Amgen's history, and added the chairmanship at the start of 2013.
Source
Apple
- John Sculley1983–1993
CEO
Sculley, a Wharton MBA who had built his reputation running Pepsi's marketing organization, was recruited to Apple in 1983 after Steve Jobs asked him, 'Do you want to sell sugar water for the rest of your life, or do you want to change the world?' Apple paid h…
Source - Gil Amelio1996–1997
CEO
Amelio built his reputation as a corporate turnaround specialist at Rockwell International and then as CEO of National Semiconductor, where he was credited with transforming it from a struggling third-tier chipmaker into a more respected competitor, before joi…
Source - Steve Jobs1997–2011
CEO
Jobs enrolled at Reed College but dropped out after six months, later working as a video-game designer at Atari before he and Steve Wozniak founded Apple Computer in the Jobs family garage in 1976, funding the venture by selling Jobs's Volkswagen van and Wozni…
Source - Tim Cook2011–2026
CEO
Cook earned an industrial-engineering degree from Auburn University and an MBA from Duke's Fuqua School of Business, then spent 12 years at IBM's personal-computer business before serving as COO of the reseller division at Intelligent Electronics and briefly a…
Source - John Ternus2026–present
CEO
Before becoming CEO, Ternus was Apple's senior vice president of Hardware Engineering, the group responsible for the engineering of Apple's devices. Cook described his contributions to Apple as spanning 25 years when the succession was announced.
Source
Timeline: Amgen and Apple side by side
1976Apple
Apple is founded by Steve Jobs, Steve Wozniak, and Ronald Wayne, turning an early personal-computer board into a company with a product and a market.
Steve Jobs, Steve Wozniak, and Ronald Wayne founded Apple in 1976, when personal computing was still a hobbyist market.
1977Apple
The Apple II launches and gives the young company an expandable personal computer for schools, homes, and small businesses.
The Apple II turned a garage project into a business. Color graphics, expansion slots and a consumer-friendly design carried it into schools, homes and small offices, giving Apple a revenue base years before the Macintosh.
1980Amgen
Applied Molecular Genetics is incorporated
Applied Molecular Genetics (AMGen) was incorporated on April 8, 1980 in Thousand Oaks, California, as the idea of venture capitalist William K. Bowes Jr. and a group of scientific collaborators.
1980Apple
Apple completes its initial public offering in December 1980, raising capital and turning personal computing into a public-market story.
The December 1980 IPO gave Apple public-market capital and made personal computing look like a serious commercial category. It also raised the pressure to professionalize management, distribution and product planning as the company outgrew its founding team.
1983Amgen
Nasdaq listing and the erythropoietin clone
Amgen completed its initial public offering on June 17, 1983, raising nearly US$40 million under chief financial officer Gordon Binder, and formally shortened its name to Amgen.
1984Amgen
Kirin-Amgen joint venture formed
Amgen and Kirin Brewery Company of Japan formed Kirin-Amgen in 1984 as a joint venture for the worldwide commercialization of erythropoietin.
1984Apple
The Macintosh introduces a graphical interface and mouse-driven computing to a broad audience at a $2,495 launch price.
The Macintosh brought a graphical interface and a mouse to a mass-market computer and defined Apple's design identity.
1985Amgen
G-CSF cloned, leading to Neupogen
While Fu-Kuen Lin's team worked on erythropoietin, researcher Larry Souza and his group cloned and expressed human granulocyte colony-stimulating factor in 1985.
1989Amgen
FDA approves Epogen
The FDA approved Epogen (epoetin alfa) on June 1, 1989 for anemia in patients with chronic kidney failure on dialysis. It was the first commercial recombinant human erythropoietin. Epogen's U.S.
1991Amgen
Neupogen approved, giving Amgen a second franchise
The FDA approved Neupogen (filgrastim) in February 1991. By stimulating white blood cell production it reduced the risk of infection in cancer patients with chemotherapy-induced neutropenia.
1991Amgen
Amgen wins the erythropoietin patent fight
On March 6, 1991 the U.S. Court of Appeals for the Federal Circuit upheld the Kirin-Amgen erythropoietin patent and ruled against Genetics Institute in Amgen v. Chugai Pharmaceutical and Genetics Institute.
1997Apple
Apple completes the NeXT acquisition, bringing Steve Jobs back and supplying the operating-system foundation for the years that followed.
Apple's NeXT acquisition brought Steve Jobs back when the company was financially weak and unfocused.
2001Amgen
FDA approves Aranesp, the longer-acting EPO
Aranesp (darbepoetin alfa), an erythropoietin analogue with modified glycosylation and a longer half-life, was approved in 2001. Less frequent dosing than Epogen improved convenience and gave Amgen a newer, higher-priced product to migrate patients toward.
2001Apple
Apple introduces the iPod on October 23, 2001, a 5GB music player priced at $399 that held about 1,000 songs.
The iPod put a hard-drive music library in a pocket at $399 and went on sale on November 10, 2001.
2002Amgen
US$16 billion Immunex acquisition brings Enbrel in-house
Amgen completed its acquisition of Immunex Corporation on July 16, 2002, the largest biotechnology deal to that point at about US$16 billion in stock and cash.
2007Apple
The iPhone is introduced as a phone, widescreen iPod, and internet communicator, moving Apple into the center of mobile computing.
The iPhone moved Apple into mobile computing and shifted the company's center of gravity away from the Mac. It also created the hardware base that later supported services, accessories and developer economics.
2008Apple
The App Store opens with 500 apps, creating a controlled software marketplace that becomes a major Services pillar.
The App Store launched with 500 apps and gave iPhone owners a single, controlled way to install third-party software.
2010Amgen
Prolia and XGEVA create the bone health franchise
The FDA approved Prolia (denosumab) for postmenopausal osteoporosis in June 2010 and XGEVA, the same molecule at a higher dose, for prevention of skeletal-related events in cancer patients in November 2010.
2011Apple
Tim Cook becomes chief executive on August 24, 2011, after Steve Jobs resigns and the board names Cook to succeed him.
Apple's board named Tim Cook chief executive on August 24, 2011, when Steve Jobs resigned and recommended the succession plan be carried out.
2014Apple
Apple agrees to acquire Beats Music and Beats Electronics for $3 billion, its largest deal.
Apple agreed to buy Beats Music and Beats Electronics for a total of $3 billion, about $2.6 billion in purchase price plus roughly $400 million vesting over time, and brought in founders Jimmy Iovine and Dr. Dre.
2019Amgen
US$13.4 billion purchase of Otezla from Celgene
Amgen agreed in August 2019 to buy worldwide rights to Otezla (apremilast) from Celgene for US$13.4 billion in cash, or about US$11.2 billion net of the present value of US$2.2 billion of anticipated future cash tax benefits, and closed on November 21, 2019.
2020Amgen
Amgen joins the Dow Jones Industrial Average
Amgen replaced Pfizer in the Dow Jones Industrial Average on August 31, 2020, becoming one of the thirty components in the index. Inclusion recognized the scale Amgen had reached and added passive demand from Dow-tracking funds.
2020Apple
Apple announces the Mac transition to Apple silicon, deepening control over performance, power efficiency, and software optimization.
Apple began moving Mac computers off Intel processors and onto its own M-series chips in 2020.
2023Amgen
US$27.8 billion Horizon Therapeutics acquisition closes
Amgen completed the acquisition of Horizon Therapeutics plc on October 6, 2023 for US$116.50 per share in cash, an equity value of about US$27.8 billion, after settling FTC litigation with a behavioral consent decree.
2024Amgen
Imdelltra becomes the first T-cell engager for small cell lung cancer
The FDA granted accelerated approval to tarlatamab, sold as Imdelltra, on May 16, 2024 for extensive stage small cell lung cancer that has progressed on or after platinum-based chemotherapy.
2024Apple
Vision Pro launches at $3,499 and gives Apple a shipping platform for spatial interfaces, sensors, and custom silicon.
Vision Pro gave Apple a live platform for spatial interfaces, eye and hand input, high-resolution displays and custom chips.
2025Amgen
VESALIUS-CV extends the Repatha case to primary prevention
In November 2025 Amgen reported Phase 3 VESALIUS-CV results in more than 12,000 patients with atherosclerosis or diabetes but no prior heart attack or stroke.
2026Amgen
Medicare price setting reaches Enbrel and Otezla
Enbrel's negotiated Medicare price under the Inflation Reduction Act took effect on January 1, 2026, after it was named in the first round of ten drugs selected for negotiation.
2026Apple
John Ternus becomes chief executive on September 1, 2026, and Tim Cook becomes executive chairman.
John Ternus, Apple's senior vice president of Hardware Engineering, became chief executive on September 1, 2026, and Tim Cook became executive chairman after 15 years as CEO.
Acquisitions
Amgen
- Horizon Therapeutics plc2023$27.8B
- ChemoCentryx, Inc.2022$3.7B
- Five Prime Therapeutics2021$1.9B
- Celgene Otezla Business2019$13.4B
- Onyx Pharmaceuticals, Inc.2013$10.4B
- DeCODE Genetics2012$415M
Questions about Amgen vs Apple
Who is the CEO of Amgen Inc. and Apple Inc.?
Amgen Inc. is led by Robert A. Bradway and Apple Inc. is led by John Ternus. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was Amgen Inc. founded vs Apple Inc.?
Apple Inc. was founded in 1976 — 4 years before Amgen Inc., which was founded in 1980. Apple Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger Amgen Inc..
How many employees does Amgen Inc. have compared to Apple Inc.?
Amgen Inc. employs approximately 31,500 people, while Apple Inc. employs approximately 166,000. Apple Inc. has the larger workforce at 166,000 employees, compared to Amgen Inc.'s 31,500. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are Amgen Inc. and Apple Inc. headquartered?
Both Amgen Inc. and Apple Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded Amgen Inc. and Apple Inc.?
Amgen Inc. was founded by George B. Rathmann, William K. Bowes Jr.. Apple Inc. was founded by Steve Jobs, Steve Wozniak, Ronald Wayne.
Which company has a longer operating history — Amgen Inc. or Apple Inc.?
Apple Inc. has been operating for approximately 50 years, making it the more established of the two companies. Amgen Inc. has been in operation for around 46 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the Amgen vs Apple overview